2-Alkyl(aryl)-quinazolin-4(3H)-thiones, 2-R-(quinazolin-4(3H)-ylthio)carboxylic acids and amides: synthesis, molecular docking, antimicrobial and anticancer properties

References

• Zheng Y, Bian M, Deng X-Q, et al. Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines. Arch Pharm 2013;346:119–26
   PubMed Web of Science ®Google Scholar
• Lee NK, Lee JW, LEE S404-904 J Apt., et al. SK Chemicals Co., Ltd.; Leadgenex Inc; Industry Academic Cooperation Foundation of Kyunghee University, Eur Pat EP 1844023 A1, 2007
   Google Scholar
• Wu J, Bai S, Yue M, et al. Synthesis and insecticidal activity of 6,8-dichloroquinazoline derivatives containing a sulfide substructure. Chem Pap 2014;68:969–75
   Web of Science ®Google Scholar
• Nomoto T, Ohno K. Studies on cardiotonic agents. VII. Potent cardiotonic agent KF15232 with myofibrillar Ca2+ sensitizing effect. Chem Pharm Bull 1991;39:900–10
   PubMed Web of Science ®Google Scholar
• Thornton TJ, Jones TR, Jackman AL, et al. Quinazoline antifolates inhibiting thymidylate synthase: 4-thio-substituted analogs. J Med Chem 1991;34:978–84
   PubMed Web of Science ®Google Scholar
• Patrick A, Green TP, Hennequin LF, et al. Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src. J Med Chem 2004;47:871–87
   PubMed Web of Science ®Google Scholar
• Sanchez AI, Martinez-Barrasa V, Burgos C, et al. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors. Bioorg Med Chem 2013;21:2370–8
   PubMed Web of Science ®Google Scholar
• Kune JI, Jaroslav B, Pour M, et al. Quinazoline derivatives with antitubercular activity. Farmaco 2000;55:725–9
   PubMedGoogle Scholar
• Xu G-F, Song B-A, Bhadury PS, et al. Synthesis and antifungal activity of novel s-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives. Bioorg Med Chem 2007;15:3768–74
   PubMed Web of Science ®Google Scholar
• Shalaby AA, El-Khamry AMA, Shiba A, et al. Synthesis and antifungal activity of some new quinazoline and benzoxazinone derivatives. Arch Pharm 2000;333:365–72
   PubMed Web of Science ®Google Scholar
• Shiba SH, El-Rhamry AA, Shaban ME, Atia KS. Synthesis and antimicrobial activity of some bis-quinazoline derivatives. Pharmazie 1997;52:189–94
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman HM, El-Koussi NA, Hassan HY. Fluorinated 1,2,4-triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents. Arch Pharm 2009;342:94–9
   PubMed Web of Science ®Google Scholar
• Yu Z, Shi G, Sun Q, et al. Design, synthesis and in vitro antibacterial/antifungal evaluation of novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)quinoline-3-carboxylic acid derivatives. Eur J Med Chem 2009;44:4726–33
   PubMed Web of Science ®Google Scholar
• Saravanan G, Alagarsamy V, Prakash CR. Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)-one derivatives. Med Chem Res 2013;22:340–50
   Web of Science ®Google Scholar
• El-Azab AS, Al-Omar MA, Abdel-Aziz Al A-M, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem 2010;45:4188–98
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Abdel-Aziz Al A-M, Al-Suwaidan IA, et al. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Eur J Med Chem 2014;79:446–54
   PubMed Web of Science ®Google Scholar
• Kumar S, Agrawal R. Next generation tyrosine kinase inhibitor (TKI): Afatinib. Recent Pat Anticancer Drug Discov 2014;9:382–93
   PubMed Web of Science ®Google Scholar
• Tomisek AJ, Christensen BT. Quinazolines. VI. Syntheses of certain 2-methyl-4-substituted quinazolines. J Am Chem Soc 1948;70:2423–5
   Web of Science ®Google Scholar
• Alvarez J, Shoichet B. Virtual screening in drug discovery. Boca Raton, FL: CRC Press, Taylor & Francis; 2005
   Google Scholar
• Fred Receptor2.2.5, Vida4.1.1, Flipper, Babel3, Omega2.4.3 and Fred2.2.5: OpenEye Sci. Soft Inc Santa Fe, NM, USA, 2011. Available from: http://www.eyesopen.com
   Google Scholar
• Protein Data Bank, pdb. Available from: http://www.pdb.org
   Google Scholar
• Boyd MR. The NCI in vitro anticancer drug discovery screen: concept, implementation and operation. Totowa, NJ: Humana Press; 1997
   Google Scholar
• Kunes J, Bazant J, Pour M, et al. Quinazoline derivatives with antitubercular activity. Farmaco 2000;55:725–9
   PubMedGoogle Scholar
• Lygin AV, Meijere A. Ortho-lithiophenyl isocyanide: a versatile precursor for 3H-quinazolin-4-ones and 3H-quinazolin-4-thiones. Org Lett 2009;11:389–92
   PubMed Web of Science ®Google Scholar
• Kovalenko SM, Vlasov SV, Silin OV, Chernykh VP. Recyclization of 2-imino-2H-1-benzopyrans under the action of nucleophilic reagents: the novel approach for 2-(coumarin-3-yl)-3H-quinazolin-4-thiones. J Sulf Chem 2009;30:53–63
   Web of Science ®Google Scholar
• Salah SI, Ali MA-H, Yassien G, et al. Synthesis and biological evaluation of some new fused quinazoline derivatives. J Chem Res 1997:154–5
   Web of Science ®Google Scholar
• Whitlow W, Howard AJ, Stewart D, et al. X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complex. J Biol Chem 1997;272:30289–98
   PubMed Web of Science ®Google Scholar
• Hawser S, Lociuro S, Islam K. Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol 2006;71:941–8
   PubMed Web of Science ®Google Scholar
• Bliesath J, Huser N, Omoric M, et al. Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells. Cancer Lett 2012;322:113–18
   PubMed Web of Science ®Google Scholar